Theriva Biologics
TOVX
TOVX
46 hedge funds and large institutions have $7.28M invested in Theriva Biologics in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
46
Holding in Top 10
–
Calls
$1.2M
Puts
–
Top Buyers
| 1 | +$56.5K | |
| 2 | +$28K | |
| 3 | +$8K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$8K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$5K |
Top Sellers
| 1 | -$64.7K | |
| 2 | -$31K | |
| 3 | -$19K | |
| 4 |
SFSIG
San Francisco Sentry Investment Group
San Francisco,
California
|
-$17K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$12.3K |